Elevated eosinophil count is related with lower anti-factor Xa activity in COVID-19 patients

Despite prophylactic anticoagulant treatments, thrombotic complications may develop in patients with coronavirus disease 2019 (COVID-19). This study aimed to evaluate the factors influencing anti-factor Xa activity in COVID-19 patients receiving low molecular weight heparin (LMWH). We prospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Ari, Selma, Can, Veysi, Demir, Ömer Furkan, Ari, Hasan, Ağca, Fahriye Vatansever, Melek, Mehmet, Çamci, Sencer, Dikiş, Özlem Şengören, Huysal, Kağan, Türk, Tamer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541761/
https://www.ncbi.nlm.nih.gov/pubmed/33046998
http://dx.doi.org/10.1007/s12308-020-00419-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541761/
https://www.ncbi.nlm.nih.gov/pubmed/33046998
http://dx.doi.org/10.1007/s12308-020-00419-3

Ejemplares similares